Study for Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery


About this study

The purpose of this study is to evaluate the impact of patient input on opioid prescribing and overall opioid use following gynecologic surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female patients >18 years old.
  • Ability to provide informed consent.
  • Planned minimally invasive hysterectomy with the Department of Surgery.
    • Concomitant minimally invasive surgeries performed by Gynecology will be allowed.

Exclusion Criteria:

  • Non-English speaking.
  • Combined surgical cases with other surgical departments.
  • Planned laparotomy.
  • Surgery planned to last >4 hours.
  • Postoperative hospitalization planned for >7 days.
  • Planned use of oral opioids other than oxycodone postoperatively.
  • Pre-existing chronic pain conditions including: chronic pelvic pain, migraines, temporomandibular joint dysfunction syndrome, fibromyalgia, and interstitial cystitis.
  • Preoperative diagnosis of pelvic pain.
  • Chronic preoperative opioid use.
  • History of or current diagnosis of narcotic or alcohol dependence:
    • Screening question asked at preoperative appointment:Have you or are you currently dependent on narcotic medications or alcohol?
  • Desire for more opioids than standard therapy.
  • Postoperative decision of surgeon to prescribed more than standard therapy.
  • Allergy or contraindication to taking opioids, ibuprofen, or acetaminophen.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Johnny Yi, M.D.

Closed for enrollment

More information


Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions